Related Experiment Video
Updated: May 10, 2026
08:53
Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
Ginsenoside Rd for acute ischemic stroke: translating from bench to bedside
Ruidong Ye1, Gang Zhao, Xinfeng Liu
1Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
Expert Review of Neurotherapeutics
|June 7, 2013
Summary
Ginsenoside Rd shows promise as a neuroprotective agent for acute ischemic stroke, despite challenges in translating neuroprotection therapies to clinical practice. Further research validates its potential therapeutic mechanisms and efficacy.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Acute ischemic stroke involves complex pathophysiological mechanisms.
- Neuroprotective strategies aim to impede the ischemic cascade but face clinical translation challenges.
- Ginsenoside Rd, derived from ginseng, demonstrates neuroprotective effects in preclinical and clinical studies.
Purpose of the Study:
- To provide a comprehensive overview of Ginsenoside Rd.
- To evaluate its potential as a neuroprotective agent for acute ischemic stroke.
Main Methods:
- Review of physiochemical properties.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Assessment of clinical efficacy and safety data.
- Exploration of putative therapeutic mechanisms.
Main Results:
- Ginsenoside Rd exhibits encouraging neuroprotective efficacy.
- The article synthesizes data on its profile, action, and safety.
Conclusions:
- Ginsenoside Rd presents a valid therapeutic candidate for acute ischemic stroke.
- Its established efficacy and safety profile warrant further clinical consideration.